Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB. (Q44010395)
Jump to navigation
Jump to search
scientific article published on 7 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB. |
scientific article published on 7 December 2012 |
Statements
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB (English)
Yuehui Wang
Weixia Sun
Bing Du
Xiao Miao
Yang Bai
Ying Xin
Yi Tan
Wenpeng Cui
Bin Liu
Taixing Cui
Yaowen Fu
7 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference